Articles tagged with Immune Regulation
Dr. Anthony Fauci is being recognized for his significant contributions to science and medicine, particularly in the fields of immunology and infectious diseases. He has made numerous groundbreaking research discoveries and has been a key figure in shaping public policy during the COVID-19 pandemic.
Researchers at UCalgary's Snyder Institute for Chronic Diseases have unlocked new insights into the regulation of immunity against chronic infectious diseases. The study found that immune responses thought to be non-protective are actually essential in regulating excessive inflammation, which can facilitate infection.
Researchers have isolated specific cells that can target rogue immune T-cells, potentially rebooting the immune system. This 'antigen-specific immunotherapy' shows promise in treating existing inflammatory autoimmune diseases.
Scientists have created a retroviral CRISPR-Cas9 gene editing library to explore the regulation of mouse T cells, mapping the most important genes for controlling T helper cells and identifying several new regulatory genes. This could help develop new treatments to activate the immune system.
Researchers at Helmholtz Munich have discovered a new cofactor, NUFIP2, that works with Roquin to regulate the immune response. This cooperative regulation helps limit immune responses to specific reactions and prevents inflammatory reactions.
Researchers have made a breakthrough in treating autoimmune diabetes using genetically modified gut bacteria, increasing the frequency of cured mice compared to traditional methods. The new approach has no adverse side effects and allows the immune system to function normally.
A new study found that growing up on a farm increases regulatory T-lymphocytes, cells that damp down the immune system and limit immune responses. This shift in cell ratio is associated with reduced antibody responses to food proteins and lower risk of allergies.
Researchers at Goethe University Frankfurt have elucidated a new signaling pathway in the immune system that regulates inflammation and chronic dermatitis. The discovery provides new avenues for therapeutic intervention and potential targeted therapy for patients with unclear origin.
Scientists at Goethe University report a paradigm shift in immune response regulation, revealing the crucial role of linear ubiquitin chains in nuclear factor kappa B activation. This finding may lead to structure-based drug design for targeting the NF-κB pathway in diseases such as cancer and inflammation.
A double-blind study found that immunomodulation therapy reduced the risk of death from any cause or subsequent first hospitalisation for cardiovascular reasons by 8%. In subgroups with no history of heart attack, IMT was associated with a 26% reduction in primary events.
Researchers developed a novel assay to examine T cell responses to autoantigens in islet cells, revealing distinct pathways of T cell differentiation and maturation in normal individuals versus patients with T1DM. These findings suggest proinflammatory polarization in diabetes but regulatory phenotypes in health.
Dr. Anthony S. Fauci has been recognized for his significant contributions to understanding the regulation of the human immune response and the pathogenesis of HIV disease. He has developed effective therapies for formerly fatal diseases and has pioneered strategies for therapy and immune reconstitution of patients with AIDS.
Researchers found that perforin, crucial for destroying abnormal cells, also plays a regulatory role in controlling the immune system's response to infections. This discovery may lead to new treatments and cures for diseases like lupus and multiple sclerosis.